Mortality and survival¶
The following parameter determine mortality and survival characteristics of the disease being modeled and the population in general (non-disease mortality).
Note
Parameters are case-sensitive. For Boolean parameters, set to 1 for true or 0 for false. Minimum, maximum, or default values of “NA” indicate that those values are not applicable for that parameter.
EMOD does not use true defaults; that is, if the dependency relationships indicate that a parameter is required, you must supply a value for it. However, many of the tools used to work with EMOD will use the default values provided below.
JSON format does not permit comments, but you can add “dummy” parameters to add contextual information to your files. Any keys that are not EMOD parameter names will be ignored by the model.
Parameter |
Data type |
Minimum |
Maximum |
Default |
Description |
Example |
---|---|---|---|---|---|---|
ART_CD4_at_Initiation_Saturating_Reduction_in_Mortality |
float |
0 |
3.40E+38 |
350 |
The duration from ART enrollment to on-ART HIV-caused death increases with CD4 at ART initiation up to a threshold determined by this parameter value. |
{
"ART_CD4_at_Initiation_Saturating_Reduction_in_Mortality": 350
}
|
ART_Reactivation_Factor |
float |
0 |
1 |
1 |
Factor for ART reducing reactivation in HIV+. |
{
"ART_Reactivation_Factor": 0.95
}
|
CoInfection_Mortality_Rate_Off_ART |
float |
0 |
3.40282e+38 |
0 |
The daily rate of death in excess to TB when coinfected with HIV off ART. |
{
"CoInfection_Mortality_Rate_On_ART": 0.01
}
|
CoInfection_Mortality_Rate_On_ART |
float |
0 |
3.40282e+38 |
0 |
The daily rate of death in excess to TB when coinfected with HIV on ART. |
{
"CoInfection_Mortality_Rate_On_ART": 0.003
}
|
Days_Between_Symptomatic_And_Death_Weibull_Heterogeneity |
float |
0.1 |
10 |
1 |
The time between the onset of AIDS symptoms and death is sampled from a Weibull distribution; this parameter governs the heterogeneity (inverse shape) of the Weibull. |
{
"Days_Between_Symptomatic_And_Death_Weibull_Heterogeneity": 0.5
}
|
Days_Between_Symptomatic_And_Death_Weibull_Scale |
float |
1 |
3650 |
183 |
The time between the onset of AIDS symptoms and death is sampled from a Weibull distribution; this parameter governs the scale of the Weibull. |
{
"Days_Between_Symptomatic_And_Death_Weibull_Scale": 618.3
}
|
Death_Rate_Dependence |
enum |
NA |
NA |
NOT_INITIALIZED |
Determines how likely individuals are to die from natural, non-disease causes. Enable_Natural_Mortality must be set to 1. Possible values are:
Properties, rates, and bin sizes can be set for non-disease mortality for each gender in the demographics file (see Complex distributions parameters). |
{
"Death_Rate_Dependence": "NONDISEASE_MORTALITY_BY_AGE_AND_GENDER"
}
|
Enable_Disease_Mortality |
boolean |
0 |
1 |
1 |
Controls whether or not individuals are removed from the simulation due to disease deaths. |
{
"Enable_Disease_Mortality": 1
}
|
Enable_Natural_Mortality |
boolean |
0 |
1 |
0 |
Controls whether or not individuals are removed from the simulation due to natural (non-disease) deaths. Enable_Vital_Dynamics must be set to 1 (true). Use Death_Rate_Dependence to set the natural death rate. |
{
"Enable_Natural_Mortality": 1,
"Enable_Vital_Dynamics": 1
}
|
Mortality_Blocking_Immunity_Decay_Rate |
float |
0 |
1 |
0.001 |
The rate at which mortality-blocking immunity decays after the mortality-blocking immunity offset period. Enable_Immune_Decay must be set to 1. |
{
"Mortality_Blocking_Immunity_Decay_Rate": 0.1
}
|
Mortality_Time_Course |
enum |
NA |
NA |
DAILY_MORTALITY |
The method used to calculate disease deaths. Enable_Disease_Mortality must be set to 1. Possible values are:
|
{
"Mortality_Time_Course": "MORTALITY_AFTER_INFECTIOUS"
}
|
TB_Active_Mortality_Rate |
float |
0 |
1 |
0.0009589 |
The mean rate at which active smear-positive individuals die from TB disease. This is an exponential rate. In the absence of treatment, this rate is added to TB_Active_Cure_Rate and TB_Inactivation_Rate to determine the total rate of the active smear-positive state, then the ratio of TB_Active_Mortality_Rate to total rate determines the probability that an active smear-positive individual will die from TB disease after a mean duration of 1 / total rate. |
{
"TB_Active_Mortality_Rate": 5e-08
}
|
TB_Drug_Mortality_Rate |
float |
0 |
1 |
0 |
The daily rate at which treatment with an anti-TB drug causes death in an individual with drug-sensitive TB. |
{
"TB_Drug_Params": {
"BurninDrug": {
"TB_Drug_Cure_Rate": 0.0111,
"TB_Drug_Inactivation_Rate": 0,
"TB_Drug_Mortality_Rate": 0.00162,
"TB_Drug_Relapse_Rate": 0.00223,
"TB_Drug_Resistance_Rate": 0
}
}
}
|
TB_Drug_Mortality_Rate_HIV |
float |
0 |
1 |
0 |
The daily probability of death for HIV+ individual with drug sensitive active infection under drug treatment. |
{
"TBHIV_Drug_Params": {
"ACFDOTS": {
"TB_Drug_Cure_Rate": 0.25,
"TB_Drug_Inactivation_Rate": 1e-09,
"TB_Drug_Inactivation_Rate_HIV": 1e-09,
"TB_Drug_Inactivation_Rate_MDR": 1e-09,
"TB_Drug_Mortality_Rate": 1e-09,
"TB_Drug_Mortality_Rate_HIV": 1e-09,
"TB_Drug_Mortality_Rate_MDR": 1e-09,
"TB_Drug_Primary_Decay_Time_Constant": 179,
"TB_Drug_Relapse_Rate": 1e-09,
"TB_Drug_Relapse_Rate_HIV": 1e-09,
"TB_Drug_Relapse_Rate_MDR": 1e-09,
"TB_Drug_Resistance_Rate": 1e-09,
"TB_Drug_Resistance_Rate_HIV": 1e-09,
"TB_Reduced_Acquire": 1,
"TB_Reduced_Transmit": 1,
"TB_Drug_Cure_Rate_HIV": 0,
"TB_Drug_Cure_Rate_MDR": 0
},
"DOTSHQ": {
"TB_Drug_Cure_Rate": 0.008,
"TB_Drug_Inactivation_Rate": 1e-09,
"TB_Drug_Inactivation_Rate_HIV": 1e-09,
"TB_Drug_Inactivation_Rate_MDR": 1e-09,
"TB_Drug_Mortality_Rate": 0.00038,
"TB_Drug_Mortality_Rate_HIV": 0.00038,
"TB_Drug_Mortality_Rate_MDR": 0.0008,
"TB_Drug_Primary_Decay_Time_Constant": 179,
"TB_Drug_Relapse_Rate": 0.00089,
"TB_Drug_Relapse_Rate_HIV": 0.00089,
"TB_Drug_Relapse_Rate_MDR": 0.001,
"TB_Drug_Resistance_Rate": 0.0001,
"TB_Drug_Resistance_Rate_HIV": 0.0001,
"TB_Reduced_Acquire": 1,
"TB_Reduced_Transmit": 0.5,
"TB_Drug_Cure_Rate_HIV": 0.0004,
"TB_Drug_Cure_Rate_MDR": 0.0004
}
}
}
|
TB_Drug_Mortality_Rate_MDR |
float |
0 |
1 |
0 |
The daily probability of death for individual with MDR active infection under drug treatment. |
{
"TB_Drug_Mortality_Rate_MDR": 0
}
|
TB_Extrapulmonary_Mortality_Multiplier |
float |
0 |
1 |
0.4 |
The scale factor for TB_Active_Mortality_Rate to give the mortality rate of active extrapulmonary individuals. In the absence of treatment, the product is added to TB_Active_Cure_Rate and TB_Inactivation_Rate to determine the total rate of the active extrapulmonary state, then the ratio of the aforementioned product to total rate determines the probability that an active extrapulmonary individual will die from TB disease after mean duration of 1 / total rate. Extrapulmonary individuals are considered non-infectious. |
{
"TB_Extrapulmonary_Mortality_Multiplier": 1
}
|
TB_Smear_Negative_Mortality_Multiplier |
float |
0 |
1 |
0.4 |
The scale factor to increase the mortality rate set by TB_Active_Mortality_Rate for individuals with smear-negative TB. In the absence of treatment, the product is added to TB_Active_Cure_Rate and TB_Inactivation_Rate to determine the total rate of the active smear-negative state, then the ratio of the aforementioned product to total rate determines the probability that an active smear-negative individual will die from TB disease after mean duration of 1 / total rate. |
{
"TB_Smear_Negative_Mortality_Multiplier": 1
}
|
x_Other_Mortality |
float |
0 |
3.40E+38 |
1 |
Scale factor for mortality from causes other than the disease being simulated. Base mortality is provided by the demographics file (see Complex distributions parameters). Enable_Natural_Mortality must be set to 1. |
{
"x_Other_Mortality": 1
}
|